Novel intraoperative management in the model for end-stage liver disease-sodium era: Continuous venovenous hemofiltration for severe hyponatremia in liver transplantation

Authors

Shunji Nagai, Henry Ford HealthFollow
Dilip Moonka, Henry Ford HealthFollow
Anita Patel, Henry Ford HealthFollow

Recommended Citation

Nagai S, Moonka D, and Patel A. Novel intra-operative management in the meld-na era: Continuous veno-venous hemofiltration for severe hyponatremia in liver transplantation. Liver Transpl 2017; 24(2):304-307.

Document Type

Article

Publication Date

2-1-2018

Publication Title

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

Keywords

Aged, Biomarkers, End Stage Liver Disease, Female, Fluid Therapy, Hemofiltration, Humans, Hyponatremia, Intraoperative Care, Liver Cirrhosis, Liver Transplantation, Male, Middle Aged, Retrospective Studies, Severity of Illness Index, Sodium, Time Factors, Treatment Outcome, Young Adult

Medical Subject Headings

Aged; Biomarkers; End Stage Liver Disease; Female; Fluid Therapy; Hemofiltration; Humans; Hyponatremia; Intraoperative Care; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Sodium; Time Factors; Treatment Outcome; Young Adult

PubMed ID

29149464

Volume

24

Issue

2

First Page

304

Last Page

307